-, 2022, All July 13th, 2022 Comments Off on Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million

Agomab Therapeutics NV (‘Agomab’) today announced it has extended its Series B financing round with an additional close of $40.5 million (€38.4 million), bringing the total Series B amount raised to $114 million.

Read more